Assertio

ASRT

Market cap $74.8M

11.66 USD

-0.31

2.59%

At close Updated Feb 27, 4:00 PM EST

Pre-market

After hours

11.72

+0.06

0.51%

1 day

-2.59%

5 days

-0.68%

1 month

-4.89%

3 months

5.71%

6 months

0.95%

Year to date

27.57%

1 year

-2.75%

5 years

-80.42%

10 years

-98.73%

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30

Healthcare Drug Manufacturers - Specialty & Generic